IP Library Granted Patent US 10,943,687
Granted Patent B2
US 10,943,687 · App. 16/507,380 · Granted Mar 9, 2021

Expert system for insulin pump therapy

Inventor: Michael L. Blomquist (Blaine, MN)
Assignee: Tandem Diabetes Care, Inc.
G16H20/17A61M5/142A61M5/14244A61M5/1723G05B15/02G06N5/027G16H10/60G16H40/63G16H50/20A61M2005/1726A61M2205/502A61M2205/507A61M2205/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,943,687
App. No.
16/507,380
Granted
Mar 9, 2021
Kind
B2
Abstract

An apparatus including a controller can determine a rate of change of a blood glucose level of a patient and generate a pump setting based on the rate of change.

Claims (35)

1. A system comprising:

a pump configured to deliver insulin;

an input configured to receive sensor glucose data representative of a blood glucose level of a user from a continuous glucose monitor via a wireless connection; and

a controller communicatively coupled to the pump and the input, the controller configured to:

monitor the sensor glucose data from the continuous glucose monitor;

determine a rate of change of the blood glucose level of the user from the sensor glucose data;

determine, based on a current blood glucose level of the user and the rate of change of the blood glucose level, that a correction bolus should be generated;

automatically calculate the correction bolus; and

cause the pump to deliver the correction bolus to the user.

2. The system of claim 1 , wherein the controller is further configured to compare the current blood glucose level of the user and the rate of change to a predetermined high blood glucose level.

3. The system of claim 1 , wherein the controller is configured to automatically deliver the correction bolus.

4. The system of claim 1 , wherein the controller is further configured to present a recommendation to deliver the correction bolus on a user interface and to deliver the correction bolus only after receiving a confirmation in response to the recommendation.

5. The system of claim 1 , wherein the controller is configured to determine, based on a current blood glucose level of the user and the rate of change of the blood glucose level, that a correction bolus should be generated based on a comparison to a target blood glucose level.

6. The system of claim 1 , wherein the controller is configured to determine, based on a current blood glucose level of the user and the rate of change of the blood glucose level, that a correction bolus should be generated if the blood glucose level is high and increasing at a certain rate.

7. The system of claim 1 , wherein the controller is further configured to provide a notification to the user regarding the correction bolus.

8. The system of claim 1 , wherein the controller, the input and the pump are part of a common device.

9. The system of claim 1 , wherein the controller and the input are part of a handheld device that is separate from the pump.

10. A system comprising:

a pump configured to deliver insulin;

an input configured to receive sensor glucose data representative of a blood glucose level of a user from a continuous glucose monitor via a wireless connection; and

a controller communicatively coupled to the pump and the input, the controller configured to:

monitor the sensor glucose data from the continuous glucose monitor;

determine a rate of change of the blood glucose level of the user from the sensor glucose data;

determine, based on a current blood glucose level of the user and the rate of change of the blood glucose level, that a current insulin delivery pattern should be modified;

automatically calculate a modification to the insulin delivery pattern; and

cause the pump to employ the modified insulin delivery pattern.

11. The system of claim 10 , wherein when the controller determines that the current insulin delivery pattern should be modified and the rate of change indicates that the blood glucose level is increasing, the controller is configured to calculate the modification to the insulin delivery pattern by calculating an insulin correction bolus.

12. The system of claim 10 , wherein when the controller determines that the current insulin delivery pattern should be modified and the rate of change indicates that the blood glucose level is decreasing, the controller is configured to calculate the modification to the insulin delivery pattern by reducing an amount of insulin delivered.

13. The system of claim 10 , wherein the controller is further configured to compare the current blood glucose level of the user to a target blood glucose level.

14. The system of claim 13 , wherein the controller comparing the current blood glucose level to a target blood glucose level includes comparing the current blood glucose level to a target range of blood glucose levels.

15. The system of claim 10 , wherein the controller is configured to automatically deliver the modified insulin delivery pattern.

16. The system of claim 10 , wherein the controller is further configured to present a recommendation to modify the insulin delivery pattern on a user interface and to deliver the modified insulin delivery pattern only after receiving a confirmation in response to the recommendation.

17. The system of claim 10 , wherein the controller is further configured to provide a notification to the user regarding the modification to the insulin delivery pattern.

18. The system of claim 10 , wherein the controller, the input and the pump are part of a common device.

19. The system of claim 10 , wherein the controller and the input are part of a handheld device that is separate from the pump.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2024
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066880/0918 →
SECURITY INTEREST Recorded May 25, 2022
From: TANDEM DIABETES CARE, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060179/0100 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2019
From: SMITHS MEDICAL ASD, INC.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 049747/0939 →
MERGER Recorded Jul 12, 2019
From: SMITHS MEDICAL MD, INC.
To: SMITHS MEDICAL ASD, INC.
Reel/Frame 049736/0020 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2019
From: BLOMQUIST, MICHAEL L.
To: SMITHS MEDICAL MD, INC.
Reel/Frame 049711/0932 →